Comments on: Amgen’s Lumakras secures FDA nod for NSCLC with KRAS G12C mutation

Comments on: Amgen’s Lumakras secures FDA nod for NSCLC with KRAS G12C mutation /news/amgen-fda-lumakras-nsclc/ The leading site for news and procurement in the pharmaceutical industry Mon, 31 May 2021 13:27:57 +0000 hourly 1 https://wordpress.org/?v=6.7.2